Upregulation of cystatin M during the progression of oropharyngeal squamous cell carcinoma from primary tumor to metastasis

被引:45
作者
Vigneswaran, N
Wu, J
Zacharias, W
机构
[1] Univ Louisville, Dept Med, Louisville, KY 40202 USA
[2] Univ Texas, Houston Dent Branch Stomatol, Dept Diagnost Sci, Houston, TX 77030 USA
[3] Univ Louisville, Dept Pharmacol & Toxicol, James Graham Brown Canc Ctr, Louisville, KY 40202 USA
关键词
oral carcinoma; metastasis; cystatin M; cathepsin B; apoptosis;
D O I
10.1016/S1368-8375(03)00038-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To identify metastasis-associated molecules in oropharyngeal squamous cell carcinomas (OSCC), we recently compared mRNA expression profiles of cell lines derived from primary and metastatic lesions of OSCC using microarray technology. Cystatin M, an endogenous cathepsin B inhibitor, was expressed 40-fold higher in the metastatic versus the primary tumor cell line. To show that different cystatin expression levels affect the cell lines' sensitivities to TNF-induced apoptosis by differentially regulating cathepsin B activity. The 686Tu and 686Ln cell lines were established from a 49-year-old male patient with an OSCC involving the posterior tongue and oro-pharynx (tumor stage T3N3B). RT-PCR, Western blots, immunohistochemistry, and in situ hybridization all confirmed increased cystatin M expression in 686Ln compared to 686Tu cells, and in the parent archival tumors. TNF-alpha induced apoptosis was easily detected in 686Tu, but only marginally in 686Ln cells. Thus, we propose that elevated cystatin M expression aids metastasis by blocking intrinsic cathepsin B activity and rescuing tumor cells from TNF-induced apoptosis. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:559 / 568
页数:10
相关论文
共 33 条
[1]  
ABRAHAMSON M, 1994, METHOD ENZYMOL, V244, P685
[2]   Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice [J].
Cretney, E ;
Takeda, K ;
Yagita, H ;
Glaccum, M ;
Peschon, JJ ;
Smyth, MJ .
JOURNAL OF IMMUNOLOGY, 2002, 168 (03) :1356-1361
[3]   Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor [J].
Foghsgaard, L ;
Wissing, D ;
Mauch, D ;
Lademann, U ;
Bastholm, L ;
Boes, M ;
Elling, F ;
Leist, M ;
Jäättelä, M .
JOURNAL OF CELL BIOLOGY, 2001, 153 (05) :999-1009
[4]   Molecular regulation, membrane association and secretion of tumor cathepsin B [J].
Frosch, BA ;
Berquin, I ;
Emmert-Buck, MR ;
Moin, K ;
Sloane, BF .
APMIS, 1999, 107 (01) :28-37
[5]   Apoptosis and metastasis: A superior resistance of metastatic cancer cells to programmed cell death [J].
Glinsky, GV ;
Glinsky, VV .
CANCER LETTERS, 1996, 101 (01) :43-51
[6]   TRAIL: a molecule with multiple receptors and control mechanisms [J].
Griffith, TS ;
Lynch, DH .
CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) :559-563
[7]   Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c [J].
Guicciardi, ME ;
Deussing, J ;
Miyoshi, H ;
Bronk, SF ;
Svingen, PA ;
Peters, C ;
Kaufmann, SH ;
Gores, GJ .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (09) :1127-1137
[8]   Leukocystatin, a new class II cystatin expressed selectively by hematopoietic cells [J].
Halfon, S ;
Ford, J ;
Foster, J ;
Dowling, L ;
Lucian, L ;
Sterling, M ;
Xu, YM ;
Weiss, M ;
Ikeda, M ;
Liggett, D ;
Helms, A ;
Caux, C ;
Lebecque, S ;
Hannum, C ;
Menon, S ;
McClanahan, T ;
Gorman, D ;
Zurawski, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (26) :16400-16408
[9]  
Henskens YMC, 1996, BIOL CHEM H-S, V377, P71
[10]  
Kuopio T, 1998, CANCER RES, V58, P432